APA (7th ed.) Citation

MA, D., F, E., J, L., NJ, R. S., DM, C., E, G., . . . X, L. (2026). Cytologic atypia is predictive of increased risk of malignancy and BRAF mutations in thyroid follicular neoplasms (Bethesda category IV). Journal of the American Society of Cytopathology, 15(2), 113. https://doi.org/10.1016/j.jasc.2025.07.003

Chicago Style (17th ed.) Citation

MA, Dean, et al. "Cytologic Atypia Is Predictive of Increased Risk of Malignancy and BRAF Mutations in Thyroid Follicular Neoplasms (Bethesda Category IV)." Journal of the American Society of Cytopathology 15, no. 2 (2026): 113. https://doi.org/10.1016/j.jasc.2025.07.003.

MLA (9th ed.) Citation

MA, Dean, et al. "Cytologic Atypia Is Predictive of Increased Risk of Malignancy and BRAF Mutations in Thyroid Follicular Neoplasms (Bethesda Category IV)." Journal of the American Society of Cytopathology, vol. 15, no. 2, 2026, p. 113, https://doi.org/10.1016/j.jasc.2025.07.003.